Solid Tumor Malignancies
Also known as: Solid Tumor Malignancy / Solid Malignancies / Solid Malignancy
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00049 | Rasburicase | A recombinant form of urate-oxidase enzyme used to treat hyperuricemia following chemotherapy for leukemias and non-Hodgkin's lymphoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00049 | Rasburicase | Uric acid | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12588 | AZD-1480 | 1 | Terminated | 1 |
| DB06626 | Axitinib | 1 | Completed | 1 |
| DB01248 | Docetaxel | 1 | Completed | 1 |
| DB01248 | Docetaxel | 1 | Recruiting | 1 |
| DB11714 | Durvalumab | 1 | Active Not Recruiting | 1 |
| DB00947 | Fulvestrant | 1 | Completed | 1 |
| DB12047 | Ganetespib | 1 | Completed | 1 |
| DB06721 | Gimatecan | 1 | Completed | 1 |
| DB05036 | Grn163l | 1 | Completed | 1 |
| DB04845 | Ixabepilone | 1 | Completed | 1 |
| DB01229 | Paclitaxel | 1 | Completed | 1 |
| DB12893 | Sacituzumab govitecan | 1 | Recruiting | 1 |
| DB12384 | Silatecan | 1 | Completed | 1 |
| DB16732 | Tisotumab vedotin | 1 | Completed | 1 |
| DB11771 | Tremelimumab | 1 | Active Not Recruiting | 1 |
| DB00755 | Tretinoin | 1 | Terminated | 1 |
| DB06235 | Vadimezan | 1 | Terminated | 1 |
| DB00313 | Valproic acid | 1 | Terminated | 1 |
| DB11925 | Vistusertib | 1 | Completed | 1 |
| DB00762 | Irinotecan | 1 / 2 | Withdrawn | 1 |
| DB16845 | Roblitinib | 1 / 2 | Completed | 1 |
| DB11942 | Selinexor | 1 / 2 | Withdrawn | 1 |
| DB14892 | Spartalizumab | 1 / 2 | Completed | 1 |
| DB01590 | Everolimus | 2 | Completed | 1 |
| DB15654 | Moderna COVID-19 Vaccine | 2 | Completed | 1 |
| DB00019 | Pegfilgrastim | 2 | Terminated | 1 |
| DB00019 | Pegfilgrastim | 2 | Unknown Status | 1 |
| DB15102 | Pemigatinib | 2 | Terminated | 1 |
| DB05332 | Romiplostim | 3 | Recruiting | 1 |